Gout, a form of inflammatory arthritis, often characterized by painful attacks, has long been managed through urate-lowering therapy (ULT). However, a recognized gap in care has led researchers to explore simpler ULT regimens that not only effectively target serum urate levels but also improve the overall quality of gout treatment. In a recent comparative effectiveness […]
Indore: Through a recent press note, the All India Organization of Chemists and Druggists (AIOCD) has informed that Jagannath Shinde and Rajiv Singhal have been unanimously reelected as President and General Secretary of AIOCD. This announcement was made during its triannual general meeting in the cleanest city in India, Indore. The meeting addressed significant issues […]
In the quest to understand and combat young-onset dementia (YOD), a groundbreaking study has delved into previously unexplored territory, shedding light on modifiable risk factors that could revolutionize preventive initiatives. In a groundbreaking prospective cohort study utilizing data from the UK Biobank, researchers sought to unravel the factors associated with the incidence of YOD in […]
Delhi: INI SS January 2024 Round 2 counselling by All India Institute of Medical Sciences (AIIMS) is going to begin on 3rd January 2023. As per the schedule, the announcement of the institute allocation of 2nd round will be done on 3rd January 2024. The online acceptance of the allocated institute from 4th January 2024, […]
New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major Novartis protocol amendment request for Ofatumumab study. This came after the firm presented protocol amendment version 03 dated 13 April 2023, Protocol no. COMB157G2399. The study is an Open-label, single-arm, Multi-center Extension Study Evaluating […]
New Delhi: Reviewing the drug major Hetero Lab’s revised Phase III clinical trial protocol of fixed-dose combination antidiabetic drug Sitagliptin plus Metformin plus Voglibose, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has suggested that in the exclusion criteria, estimated glomerular filtration rate (eGFR) value should be modified as […]
New Delhi: In a significant milestone, more than 5 crore ABHA accounts have been created during the ongoing Ayushman Bhava campaign. In addition, a total of 4,44,92,564 Ayushman cards have been generated and 1,15,923 Ayushman Sabha organized. This is reflective of data up to 28.12.2023. Under the ongoing Ayushman Bhav campaign, the cumulative footfall of […]
New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol amendment request presented by drug major AstraZeneca Sodium zirconium cyclosilicate. This came after the firm presented Protocol amendment version 3.0 dated 04 Apr 2023 Protocol no. D9487C00001. The study is to evaluate the effect of […]
New Delhi: Investments worth Rs 25,813 crore have been made and 56,171 new jobs were added as of September this year under the production-linked incentive scheme for pharmaceuticals, the government said on Friday. In its year-end review, the Department of Pharmaceuticals (DoP) also said the ‘Pradhan Mantri Bhartiya Janaushadhi Pariyojana‘ achieved its target of opening 10,000 […]
Chandigarh: The Postgraduate Institute of Medical Education and Research (PGIMER) has released the counselling schedule for admission to the course for the January 2024 session. As per the notice, the counselling process will be conducted on 09.01.2024 at 12:00 Noon in the APC Auditorium, PGIMER, Chandigarh. The list of provisional qualified candidates on the basis […]